{"slideshow_credits": null, "snippet": "Novartis&#8217;s drug, Zarxio, contains the same active ingredient as Amgen&#8217;s Neupogen, and once released would become the first biosimilar in the United States.", "abstract": "United States District Court Judge Richard Seeborg denies Amgen's attempt to block sale of Novartis's recently approved biosimilar form of Neupogen, used to prevent infections in cancer patients.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [], "organization": "REUTERS", "original": "By REUTERS", "contributor": ""}, "web_url": "http://www.nytimes.com/2015/03/20/business/judge-rejects-bid-by-amgen-to-block-biosimilar-drug-by-novartis.html", "lead_paragraph": "Novartis&#8217;s drug, Zarxio, contains the same active ingredient as Amgen&#8217;s Neupogen, and once released would become the first biosimilar in the United States.", "headline": {"main": "Judge Rejects Bid by Amgen to Block Biosimilar Drug by Novartis ", "print_headline": "Business Briefing; Amgen Loses Bid to Block Biosimilar Drug by Novartis"}, "_id": "550b6aa638f0d8631c7b1173", "word_count": "258", "multimedia": [], "pub_date": "2015-03-20T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Amgen Inc", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Novartis AG", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}